Positive effects of memantine treatment in patients with moderate to severe Alzheimer's disease

被引：0
|
作者：
Gauthier, S
Wirth, Y
Moebius, HJ
机构：
[1] McGill Ctr Alzheimer & Aging, Verdun, PQ, Canada
[2] Merz Pharmaceut GmbH, Med Biometr & Data Management, Frankfurt, Germany
[3] DRA, Frankfurt, Germany
[4] Merz Pharmaceut GmbH, Res & Dev, Frankfurt, Germany
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [1] Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease
    Wirth, Y.
    Doody, R. S.
    Schmitt, F. A.
    Moebius, H. J.
    Stoeffler, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 193 - 193
  • [2] Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients
    Ferris, Steven
    Ihl, Ralf
    Robert, Philippe
    Winblad, Bengt
    Gatz, Gudrun
    Tennigkeit, Frank
    Gauthier, Serge
    [J]. ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 369 - 374
  • [3] Memantine has positive effects on behaviour in moderate to severe Alzheimer's disease
    Gauthier, S.
    Wirth, Y.
    Stoeffler, A.
    Moebius, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 188 - 188
  • [4] Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease
    Doody, R
    Wirth, Y
    Schmitt, F
    Möbius, HJ
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 227 - 232
  • [5] Effects of memantine treatment on discrete cognitive domains in patients with moderate to severe Alzheimer's disease
    Mecocci, P.
    Emre, M.
    Stender, K.
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 : 196 - 196
  • [6] Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Möbius, HJ
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
  • [7] Functional benefit of memantine treatment in patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Moebius, HJ
    Stoeffler, A
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S327 - S327
  • [8] Responders to memantine treatment in moderate to severe Alzheimer's disease
    Stöffler, A
    Ferris, SH
    Wirth, Y
    Reisberg, B
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [9] Memantine therapy in patients with moderate to severe Alzheimer's disease
    Ochudlo, S
    Targosz, M
    Liberska, A
    Opala, G
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 235 - 235
  • [10] Memantine in moderate to severe Alzheimer’s disease
    Andrew Kertesz
    [J]. Current Neurology and Neuroscience Reports, 2003, 3 (6) : 485 - 486
12345